Statements (55)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:fandom
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Fanconi_anemia_type_C
|
gptkbp:associated_with |
gptkb:fandom
increased cancer risk developmental delays thrombocytopenia solid tumors neutropenia bone marrow failure increased risk of leukemia |
gptkbp:caused_by |
FANCB gene mutation
|
gptkbp:clinical_trial |
ongoing research
stem cell research gene therapy trials new drug trials renal anomalies immunotherapy trials congenital anomalies immune deficiency pancytopenia |
gptkbp:current_use |
other types of Fanconi anemia
|
gptkbp:descendant |
X-linked recessive
|
gptkbp:discovered_by |
Fanconi
|
gptkbp:first_described_by |
gptkb:1952
|
gptkbp:genetic_diversity |
gptkb:stock_market_index
prenatal testing diagnostic tool carrier testing |
gptkbp:habitat |
X chromosome
|
https://www.w3.org/2000/01/rdf-schema#label |
Fanconi anemia type B
|
gptkbp:is_involved_in |
gptkb:stock_market_index
online communities patient advocacy organizations family support networks |
gptkbp:is_popular_in |
rare disorder
|
gptkbp:public_awareness |
gptkb:Educational_Institution
gptkb:charity community outreach programs ongoing efforts research funding initiatives |
gptkbp:research_focus |
gptkb:physicist
understanding pathophysiology new treatment options |
gptkbp:risk_factor |
radiation exposure
family history exposure to certain chemicals |
gptkbp:social_responsibility |
variable outcomes
chromosomal breakage test |
gptkbp:symptoms |
short stature
skeletal abnormalities hypopigmentation |
gptkbp:treatment |
supportive care
bone marrow transplant androgen therapy |